A case report of gadopentetate dimeglumine‐induced cardiac arrest: Resuscitation using extracorporeal membrane oxygenation
Gadopentetate dimeglumine (Gd‐DTPA) is commonly used for enhancement in magnetic resonance imaging, but rarely causes serious adverse reactions. The patient presented in this report had a cardiac arrest and multiple organ dysfunction syndrome within a short time after administration of Gd‐DTPA. Imme...
Saved in:
Published in | Annals of noninvasive electrocardiology Vol. 28; no. 3; pp. e13039 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.05.2023
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Gadopentetate dimeglumine (Gd‐DTPA) is commonly used for enhancement in magnetic resonance imaging, but rarely causes serious adverse reactions. The patient presented in this report had a cardiac arrest and multiple organ dysfunction syndrome within a short time after administration of Gd‐DTPA. Immediately after receiving an intravenous injection of Gd‐DTPA, the patient felt nausea and chest tightness, and developed systemic erythema. He was successfully treated using veno‐arterial extracorporeal membrane oxygenation (ECMO) combined with continuous renal replacement therapy without any serious complications or neurological deficits. We report a patient who was successfully treated for Gd‐DTPA‐induced cardiac arrest with ECMO. Thus, ECMO may be an effective treatment for cardiac arrest secondary to anaphylaxis.
We report a patient who was successfully treated for Gd‐DTPA‐induced cardiac arrest with veno‐arterial extracorporeal membrane oxygenation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 1082-720X 1542-474X 1542-474X |
DOI: | 10.1111/anec.13039 |